Accessibility Menu
Hitiq logo

Hitiq(ASX) HIQ

Market CapA$5.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-96%
5 Year-95%
1 Year-71%
1 Month-40%
A$0.01
+0.00%
+0.00Today
Hitiq last closing stock price
MetricPriceDate
Last closeAUD 0.012026-08-13
Hitiq stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-25%AUD 0.012026-08-06
1 month-40%AUD 0.012026-07-14
3 month-40%AUD 0.012026-05-15
Year to date-71.43%AUD 0.022025-12-31
1 year-71.43%AUD 0.022025-08-13
3 year-79.31%AUD 0.032023-08-14
5 year-94.83%AUD 0.122021-08-13
Since inception-96.29%AUD 0.162021-06-16

Hitiq Financials at a Glance

Market Cap

A$5.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$2.94M

Net Income (TTM)

-A$11.77M

EPS (TTM)

-A$0.01

P/E Ratio

-0.41

Dividend

A$0.00

Beta (Volatility)

0.16 (Low)

Price

A$0.01

Volume

670,801

Open

A$0.01

Previous Close

A$0.01

Daily Range

A$0.01 - A$0.01

52-Week Range

A$0.00 - A$0.04

Estimated Earnings Date

Nov 28, 2024

HIQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hitiq

HITIQ Limited is an Australian enterprise dedicated to developing and commercializing advanced technology for concussion management. The company’s innovative Nexus software platform provides critical data and analytical insights on head impacts, enhancing athlete care and decision-making.

Products and Services
  • Nexus software platform for concussion management
  • CoVR, a virtual reality system for cognitive assessments
  • CSX, a sideline tool for concussion evaluation
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increased awareness of concussion management boosts demand for products
  • Partnerships with sports organizations enhance market reach
Financial Highlights
  • Recent quarterly revenue of AUD 250,674 shows potential for growth
  • Trailing twelve months (TTM) revenue of AUD 2,500,000 indicates a solid foundation
  • Operating expenses reflect ongoing investment in research and development
HITIQ Limited operates in the healthcare information services sector, focusing on innovative solutions for concussion management. The Nexus platform is designed to empower athletes and medical professionals with vital data, while CoVR and CSX provide additional tools for cognitive assessment and sideline evaluations. Established in 2015 and headquartered in Melbourne, the company is positioned to capitalize on the growing awareness and need for effective concussion management solutions. Recent financial data indicates a revenue of AUD 250,674 for the latest quarter, suggesting a pathway for future growth. The TTM revenue of AUD 2,500,000 further underscores the company's potential in a market that is increasingly prioritizing athlete safety and health. As HITIQ continues to expand its product offerings and market presence, it remains a noteworthy player in the healthcare technology landscape.
AI Generated • Jul 22, 2026

Industry

Health Care Technology

CEO

Michael Dean Vegar

Headquarters

Melbourne, VIC 3205, AU

HIQ Financials

Key Financial Metrics (TTM)

Gross Margin

-77.43%

Operating Margin

-520.43%

Net Income Margin

-568.47%

Return on Equity

152.58%

Return on Capital

-351.17%

Return on Assets

-480.76%

Earnings Yield

-2.44%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$5.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

936.26M

Volume

670.80K

Avg. Volume

1.81M

Financials (TTM)

Gross Profit

-A$1.56M

Operating Income

-A$12.05M

EBITDA

-A$10.08M

Operating Cash Flow

-A$10.66M

Capital Expenditure

-A$37.56K

Free Cash Flow

-A$10.70M

Cash & ST Invst.

A$359.17K

Total Debt

A$1.53M

Hitiq Performance Analysis

Hitiq annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 612,401N/A
20232023-06-30AUD 774,26026.4%
20242024-06-30AUD 1,123,00045.0%
20252025-06-30AUD 673,250-40.0%
Hitiq sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3048.6%
Q22024-12-3153.5%
Q42025-06-30-4.5%
Q22025-12-31-74.5%
Hitiq annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.04N/A
20232023-06-30AUD -0.02-32.8%
20242024-06-30AUD -0.01-62.9%
20252025-06-30AUD -0.0270.7%
Hitiq sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3031.4%
Q22024-12-31-83.3%
Q42025-06-3018.2%
Q22025-12-3123.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$250.67K

-44.5%

Gross Profit

A$196.96K

+107.5%

Gross Margin

78.57%

N/A

Market Cap

A$5.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$224.70K

N/A

Employees

25

N/A

Net Income

-A$2.90M

-87.9%

EBITDA

-A$3.08M

-136.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$359.17K

-57.9%

Total Debt

A$1.53M

+6674.3%

Accounts Receivable

A$744.12K

+300.4%

Inventory

A$0.00

N/A

Long Term Debt

A$143.67K

N/A

Short Term Debt

A$1.39M

+6040.0%

Return on Assets

-4.81%

N/A

Return on Invested Capital

1.29%

N/A

Free Cash Flow

-A$3.14M

-151.3%

Operating Cash Flow

-A$3.14M

-153.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PER.AXPercheron Therapeutics Limited
A$0.01+11.11%
ACR.AXAcrux Limited
A$0.01-0.00%
IVX.AXInvion Limited
A$0.04+0.00%
GLH.AXGlobal Health Limited
A$0.06-7.69%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About HIQ

What is the current price of Hitiq?

Hitiq is trading at A$0.01 per share.

What is the 52-week range for Hitiq?

Over the past 52 weeks, Hitiq has traded between A$0.00 and A$0.04.

How much debt does Hitiq have?

As of the most recent reporting period, Hitiq reported total debt of A$2.07M.

How much cash does Hitiq have on hand?

Hitiq reported A$990.96K in cash and cash equivalents in its most recent financial results.

What is Hitiq’s dividend yield?

Hitiq does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.